tirzepatide fda approval 2022 Approved by FDA: In May 2022, the approved #fda (#Mounjaro) for the treatment of #type2diabetes in adults. Tirzepatide's FDA marks the first in a new class of diabetes medications Zepbound (tirzepatide) FDA Approval History
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31


























